Science Explorer Back to mapMap
Discussion
Company · Neu-Ulm · Germany

Nuvisan (Germany)

nuvisan.de/startseiteROR OpenAlex
Research works
61
▲ 94% vs 2018-21
Citations
931
15.4 per fractional work
Top-10% rate
12.3%
all institutions 10.0%
Open access
53%
world 40%
International
60%
world 18%
Nuvisan (Germany)

Not ranked overall: Nuvisan (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Nuvisan (Germany) work in?

In 2022-now, 58% of research at Nuvisan (Germany) is in Life Sciences, 28% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (27%), Immunology and Microbiology (9%). It does 3.1× the world's share of Life Sciences.

Life Sciences: 21 fractional works · 58.2% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 42.4% of its workMolecular Biology: 9 fractional works · 24.4% of its workCancer Research: 2 fractional works · 5.6% of its workCell Biology: 1 fractional works · 3.1% of its workBiotechnology: 1 fractional works · 2.9% of its workBiophysics: 1 fractional works · 2.3% of its workStructural Biology: 0 fractional works · 1.2% of its workPhysiology: 0 fractional works · 1.0% of its workMolecular Medicine: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workGenetics: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 8.7% of its workImmunology: 3 fractional works · 8.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.9% of its workPharmacology: 1 fractional works · 1.6% of its workPharmaceutical Science: 1 fractional works · 1.4% of its workToxicology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 1 fractional works · 1.8% of its workAnimal Science and Zoology: 0 fractional works · 1.0% of its workFood Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.4% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 10 fractional works · 28.4% of its workMedicine: 10 fractional works · 27.4% of its workOncology: 3 fractional works · 9.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.9% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workPharmacology: 1 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.4% of its workInfectious Diseases: 0 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.6% of its workHepatology: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workReproductive Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 1.0% of its workSmall Animals: 0 fractional works · 1.0% of its workHealth Professions: 0 fractional works · 0.0% of its workPhysical Sciences: 5 fractional works · 12.5% of its workComputer Science: 1 fractional works · 3.1% of its workComputational Theory and Mathematics: 1 fractional works · 2.2% of its workArtificial Intelligence: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 1 fractional works · 2.4% of its workMaterials Chemistry: 0 fractional works · 1.1% of its workSurfaces, Coatings and Films: 0 fractional works · 0.9% of its workBiomaterials: 0 fractional works · 0.5% of its workChemistry: 1 fractional works · 2.3% of its workOrganic Chemistry: 1 fractional works · 1.9% of its workSpectroscopy: 0 fractional works · 0.4% of its workEngineering: 1 fractional works · 2.2% of its workBiomedical Engineering: 0 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEnvironmental Chemistry: 0 fractional works · 0.5% of its workEcology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.9% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.9% of its workMathematics: 0 fractional works · 0.5% of its workStatistics and Probability: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.0% of its workALL ITS WORKNuvisan (Germany)37fractional works, 2022-now
Life Sciences58%Physical Sciences13%Health Sciences28%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1642.4%
    2. Immunology and Microbiology38.7%
    3. Pharmacology, Toxicology and Pharmaceutics13.9%
    4. Agricultural and Biological Sciences11.8%
    5. Neuroscience11.4%
    1. Medicine1027.4%
    2. Veterinary01.0%
    3. Health Professions00.0%
    1. Computer Science13.1%
    2. Materials Science12.4%
    3. Chemistry12.3%
    4. Engineering12.2%
    5. Environmental Science01.0%
    6. Physics and Astronomy00.9%
    7. Mathematics00.5%
    1. Psychology00.5%
    2. Economics, Econometrics and Finance00.2%
    3. Decision Sciences00.1%
    4. Social Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.39× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.95× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 8.62× its world share, 3 worksImmunology and Micro…Neuroscience: 0.86× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.11× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.46× its world share, 1 worksChemistryComputer Science: 0.40× its world share, 1 worksComputer ScienceEngineering: 0.15× its world share, 1 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.69× its world share, 1 worksMaterials ScienceMathematics: 0.44× its world share, 0 worksMathematicsPhysics and Astronomy: 0.41× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.01× its world share, 0 worksHealth ProfessionsMedicine: 1.43× its world share, 10 worksMedicineVeterinary: 7.38× its world share, 0 worksVeterinaryDecision Sciences: 0.13× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.11× its world share, 0 worksEconomics, Econometr…Psychology: 0.15× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.1×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics11.11×1 works
  2. Immunology and Microbiology8.62×3 works
  3. Biochemistry, Genetics and Molecular Biology7.95×16 works
  4. Veterinary7.38×0 works
  5. Chemistry1.46×1 works
  6. Medicine1.43×10 works
  7. Neuroscience0.86×0 works
  8. Materials Science0.69×1 works
  9. Mathematics0.44×0 works
  10. Physics and Astronomy0.41×0 works
  11. Computer Science0.40×1 works
  12. Agricultural and Biological Sciences0.39×1 works
  13. Environmental Science0.21×0 works
  14. Engineering0.15×1 works
  15. Psychology0.15×0 works
  16. Decision Sciences0.13×0 works
  17. Economics, Econometrics and Finance0.11×0 works
  18. Health Professions0.01×0 works

Who are the top researchers at Nuvisan (Germany)?

Ranked on the quality score, Robert J. Nelson and Christian Reh lead among researchers whose main affiliation is Nuvisan (Germany).

  1. 1 Robert J. Nelson Germany · #1,462,924 worldwide 2k citations · 64 works
  2. 2 Christian Reh Germany · #1,975,826 worldwide 333 citations · 19 works
All ranked researchers at Nuvisan (Germany)

What are the most cited papers from Nuvisan (Germany)?

The most cited paper from Nuvisan (Germany) is "Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer" (Ezra E.W. Cohen et al., 2014), with 579 citations. Next come "Solution Conformations Shed Light on PROTAC Cell Permeability" (201) and "The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium" (134).

Most cited papers
#PaperReleasedCitations
1 Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer Ezra E.W. Cohen et al. · Journal of Clinical Oncology Open access 22 Jul 2014 579
2 Solution Conformations Shed Light on PROTAC Cell Permeability Yoseph Atilaw, Vasanthanathan Poongavanam, Caroline Svensson Nilsson et al. · ACS Medicinal Chemistry Letters Open access 25 Dec 2020 201
3 The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium Ronald de Vries, Matthew D. Barfield, Nico van de Merbel et al. · Bioanalysis 5 Jul 2013 134
4 Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist Victoria E R Parker, Darren C. Robertson, Tao Wang et al. · The Journal of Clinical Endocrinology & Metabolism Open access 14 Oct 2019 122
5 JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations Srinivas Niranj Chandrasekaran et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 24 Mar 2023 110
All 59 most cited papers, with filters and sorting

Which keywords describe research at Nuvisan (Germany)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Immunotherapy, Monoclonal Antibodies, Tumor Microenvironment, Tumor Regression and Transcriptional Regulation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cancer6▲ 11×19 topics
  2. Cancer Therapy4▲ 17×12 topics
  3. Inflammation4▲ 4.6×18 topics
  4. Immunotherapy2▲ 7.4×3 topics
  5. Monoclonal Antibodies2▲ 51×3 topics
  6. Tumor Microenvironment2▲ 10×5 topics
  7. Tumor Regression2▲ 39×2 topics
  8. Machine Learning2▲ 1.24×5 topics
  9. Transcriptional Regulation2▲ 24×4 topics
  10. Pharmacokinetics1▲ 13×2 topics
  11. Angiogenesis1▲ 9.5×6 topics
  12. Lymphoma1▲ 20×2 topics
  13. Metabolism1▲ 6.2×4 topics
  14. Tumor Targeting1▲ 18×2 topics
  15. Arginine Deprivation1▲ 75×1 topic
  16. Bacterial Therapy1▲ 75×1 topic
  17. Cell Proliferation1▲ 35×3 topics
  18. Drug Discovery1▲ 13×5 topics
  19. Gene Therapy1▲ 16×2 topics
  20. Glycosylation1▲ 28×3 topics
  21. Homologous Recombination1▲ 65×2 topics
  22. Immunity1▲ 7.5×4 topics
  23. Medicinal Chemistry1▲ 11×4 topics
  24. Regulation1▲ 5.5×4 topics
  25. Clinical Trials1▲ 4.2×4 topics
  26. Epidemiology1▼ 0.70×8 topics

Which research topics does Nuvisan (Germany) publish most on?

By volume in 2022-now: Cancer Research and Treatments, Biosimilars and Bioanalytical Methods, Computational Drug Discovery Methods and Cancer, Lipids, and Metabolism.

Cancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksCancer, Lipids, and Meta…1Cancer, Lipids, and Metabolism: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksPARP inhibition in cancer therapy: 1 fractional worksProtein Structure and Dy…1Protein Structure and Dynamics: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksHippo pathway signaling and YAP/TAZ: 1 fractional works
BiotechnologyImmunologyComputational Theory and MathematicsCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Research and Treatments Biotechnology 1 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 1 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  4. 4 Cancer, Lipids, and Metabolism Cancer Research 1 works
  5. 5 Immune cells in cancer Immunology 1 works
  6. 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  7. 7 PARP inhibition in cancer therapy Oncology 1 works
  8. 8 Protein Structure and Dynamics Molecular Biology 1 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Hippo pathway signaling and YAP/TAZ Cell Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 40% of research is openly available.

with international co-authors60.0%domestic only40.0%

World: 18% is written across borders.

How has Nuvisan (Germany)'s research output changed?

Output in 2022-2025 was 94% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nuvisan (Germany) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00010%0.00020%0.00030%Nuvisan (Germany)0.000091% in 2025200020102020

Fractional works of Nuvisan (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Neu-Ulm

All research institutions in Neu-Ulm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Nuvisan (Germany). Posts are plain text and can be reported.